Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197758.RAbZQctKvT8h8p90-K9JW9DomKf9PRvODZuK_9hHg5Huw130_provenance.
• NP697044.RAbBchHFuCYAdz8F3YsbtqEy8jQzD7NqdftwAhNyNJ-bU130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697044.RAbBchHFuCYAdz8F3YsbtqEy8jQzD7NqdftwAhNyNJ-bU130_provenance.
• assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP197094.RA0ErSk_3Xu0YshA8t69tPTKGLbHjFnK88245X9GJbVeo130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197094.RA0ErSk_3Xu0YshA8t69tPTKGLbHjFnK88245X9GJbVeo130_provenance.
• assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP344181.RAc62KK8v9dmDrtB4czXcmJJBh7PIC5QDtPmESaOB9VFg130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344181.RAc62KK8v9dmDrtB4czXcmJJBh7PIC5QDtPmESaOB9VFg130_provenance.
• NP777147.RACKaMXS3wrgJ57qdXwRvwCGpsfe2KaQczNw_nI8KCbhg130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777147.RACKaMXS3wrgJ57qdXwRvwCGpsfe2KaQczNw_nI8KCbhg130_provenance.
• NP777149.RAcepg4dI6d1rMDD4JCCa45Lt32gW06RH0iQiXr7TWbyc130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777149.RAcepg4dI6d1rMDD4JCCa45Lt32gW06RH0iQiXr7TWbyc130_provenance.
• NP344129.RAhUBqExLYJYLgySp5ZMAy1km5ZTH0MeO4ddVwY4et1Vc130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344129.RAhUBqExLYJYLgySp5ZMAy1km5ZTH0MeO4ddVwY4et1Vc130_provenance.
• NP777146.RAmePfiqSFKEZhILIFsnqPZdMtvFYLn6CtR6VHJfFS4Gw130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777146.RAmePfiqSFKEZhILIFsnqPZdMtvFYLn6CtR6VHJfFS4Gw130_provenance.
• NP777148.RAn42kGAxPwvF_oA6ChB5J5ksE1os8uf_u5kwTU8jiFK8130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777148.RAn42kGAxPwvF_oA6ChB5J5ksE1os8uf_u5kwTU8jiFK8130_provenance.
• NP548254.RA9RlIvzDKdLHlpHpNMQIoj4WJlQ_uSZ_bUlUG0x5Njic130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548254.RA9RlIvzDKdLHlpHpNMQIoj4WJlQ_uSZ_bUlUG0x5Njic130_provenance.
• NP345261.RAww8p1rkRCBjgRSldQsWSAMXnuQ9bu6HlCbsEVdnEfkY130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345261.RAww8p1rkRCBjgRSldQsWSAMXnuQ9bu6HlCbsEVdnEfkY130_provenance.
• NP777142.RA7Dr3W2rDw6PqTUmQw9Luc45f7xZ83JeifJlIPQ2VNwI130_assertion description "[It is further hypothesized that MC2R blockade should allow using lower glucocorticoid doses to treat congenital adrenal hyperplasia (CAH) due to enzyme deficiency of either 21-hydroxylase (CYP21B) or 11-hydroxylase (CYP11B1), thus reaching a better final adult height than with current therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777142.RA7Dr3W2rDw6PqTUmQw9Luc45f7xZ83JeifJlIPQ2VNwI130_provenance.